
Oxford Covid vaccine shows strong immune response in older adults
Covid-19 vaccine being developed by British-Swedish pharmaceutical firm AstraZeneca and Oxford University produced a strong immune response in older adults, raising hopes that it can protect the age groups most at risk from the virus.
UP NEXT
UP NEXT
-
Budget 2021: Lower stamp duty for home buyers, funds for stressed projects, among Real Estate segment's wishlist
The Economic Times
-
Previous regimes lacked modern vision, had no metro policy: PM Modi
The Economic Times
-
Small businesses looking to sell online face a GST anomaly: FISME's Animesh Saxena
The Economic Times
-
PM Modi flags off 8 trains to Statue of Unity in Gujarat, hails Kevadiya as complete family tourist package
The Economic Times
-
PM Modi cautions against 'propaganda' as he launches India's COVID-19 vaccination drive
The Economic Times
-
Why India observes January 15 as Army Day
The Economic Times
-
Dr James Naismith: Google celebrates inventor of basketball with a doodle
The Economic Times
-
Tata Motors' Pratap Bose talks design journey of the all-new Safari
The Economic Times
-
IAF-LCA Tejas deal: Biggest indigenous defence procurement to boost Make in India initiative
The Economic Times
-
पहली बार बजट में टूटेंगी ये परंपराएं
The Economic Times
-
Budget 2021: Chemical sector should be included in PLI scheme, says Parag Jhaveri of Yasho Industries
The Economic Times
-
WhatsApp policy update: Why is it alarming users
The Economic Times
-
Budget 2021 may impose coronavirus cess, hike LTCG tax on equity: EY
The Economic Times
-
World’s largest Covid vaccination campaign: Here is all you need to know
The Economic Times
-
PM Modi at Pravasi Bharatiya Divas 2021: Ready to protect humanity with two ‘Made in India’ vaccines
The Economic Times
-
Budget 2021: SWOT analysis of FM Sitharaman’s big task at hand
The Economic Times